CN108704032A - Chinese medicine composition and its preparation method and application for conditioning and treating hepatopathy - Google Patents
Chinese medicine composition and its preparation method and application for conditioning and treating hepatopathy Download PDFInfo
- Publication number
- CN108704032A CN108704032A CN201810993245.7A CN201810993245A CN108704032A CN 108704032 A CN108704032 A CN 108704032A CN 201810993245 A CN201810993245 A CN 201810993245A CN 108704032 A CN108704032 A CN 108704032A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- extract
- medicine composition
- dandelion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine composition and its preparation method and application for conditioning and treating hepatopathy, Chinese medicine composition of the present invention is prepared by the raw material of following weight:15~25 parts of ganoderma spove powder, 15~25 parts of Ganodenna Lucidum P.E, 15~25 parts of extract of Zhuling, 15~25 parts of dandelion extract, 15~25 parts of Schisandra chinens P.E.The Chinese medicine composition chooses the Chinese medicine of integration of drinking and medicinal herbs, according to the theory of Chinese medicine " monarch ", scientific compatibility is carried out to above-mentioned five kinds of Pharmaceutical ingredients, propose effective pharmaceutical composition, the immunity of hepatopath can be enhanced, the discharge for promoting vivotoxin does not have any toxic side effect to promoting hepatopathy rehabilitation significant effect to human body.
Description
Technical field
The present invention relates to technical field of Chinese medicine, more particularly to a kind of Chinese medicine composition for conditioning and treating hepatopathy and
Preparation method and application.
Background technology
Hepatopathy is common disease and frequently-occurring disease in China, and hepatopathy can be usually divided into virus hepatitis, alcoholic liver disease, drug
Several major class such as property hepatic injury, fatty liver, hepatic sclerosis and liver cancer.Hepatitis can be divided into hepatitis A virus (HAV), hepatitis B again
Malicious (HBV), Hepatitis C Virus (HCV), Hepatitis D virus (HDV), Hepatitis E virus, fulminant hepatitis and non-icteric type
Hepatitis etc., wherein the harm of hepatitis B is maximum, incidence is also higher.As the improvement of people's living standards, alcoholic liver and fat
Fat liver etc. " rich people's disease " incidence improves year by year, and number of patients even alreadys exceed hepatitis B patient.Fatty liver is one kind by various
A kind of pathological state that reason causes liver fat deposition excessive.About 10% simple fatty liver can be to steatohepatitis rank
Section, wherein there is 20%-40% that can develop into liver fibrosis and hepatic sclerosis, eventually leads to liver cancer.Do not come to be turned by fatty liver people
The number of liver fibrosis and hepatic sclerosis is turned to about in 400-800 ten thousand.Alcoholic liver disease situation also very severe, can not be ignored.It is long
Phase heavy drinking makes liver damage, causes various alcoholic liver disease, can be divided into mild alcoholic liver, alcoholic liver, wine by degree of injury
Essence fatty liver, alcoholic fibrosis and alcoholic cirrhosis.Conservative estimation China alcoholic liver patient numbers should be 50,000,000
Left and right, is such as not treated in time, and 60% alcohol hepatopath finally translates into hepatic sclerosis even liver cancer.
By hepatitis, fatty liver, alcoholic liver patient numbers calculate liver fibrosis crowd should be 10,000,000 or so.China has more than
7000000 liver cirrhosis patient, and number of patients is on the increase.Cause the cause of disease of hepatic sclerosis very much, virus hepatitis can be divided into
Hepatic sclerosis, alcoholic cirrhosis, metabolic hepatic sclerosis, autoimmune cirrhosis etc..In China, most of hepatic sclerosis are hepatitis
Hepatic sclerosis afterwards, small part are alcoholic cirrhosis and Cirrhosis In Schistosomiasis.
This great disease of common harmfulness in face of hepatopathy, although modern medicine can effectively control the symptom of hepatopathy,
But toxic side effect is big, treatment cost is expensive.Moreover, it is a more difficult thing that hepatopathy, which is got well, can utilize a variety of
The composition of Chinese medicine carries out hepatopathy rehabilitation conditioning, and it is a new issue for being difficult to accelerate hepatopathy rehabilitation.At present, it has been reported that have
The drug for adjusting liver function has had tens of kinds, such as cordyceps sinensis, rheum officinale, Radix Notoginseng, Radix Astragali, kuh-seng, the fruit of Chinese wolfberry, Schisandra chinensis, ganoderma lucidum, strand
Stock indigo plant etc., still, the Chinese medicine preparation reported at present is very complicated, some include even ten several Chinese medicines, " are as the saying goes medicines
Three points of poison ", formula is excessively complicated, is easy to introduce the ingredient to human body toxic side effect.
Invention content
Based on this, it is necessary to a kind of Chinese medicine composition for conditioning and treating hepatopathy is provided, is had no toxic and side effect to human body, it can
To enhance the immunity of hepatopath, promote hepatopathy rehabilitation.
A kind of Chinese medicine composition for conditioning and treating hepatopathy, the Chinese medicine composition by following weight raw material
Composition:
Ganoderma lucidum and ganoderma spove powder, for the monarch drug in a prescription of the present invention.Ganoderma lucidum (Ganoderma lucidum), as drug
First recorded in《Sheng Nong's herbal classic》, reinforcement can be moistened and strengthened, strengthen the body resistance to consolidate the constitution, promote longevity, there is high medical value and health care work(
Effect.Ganoderma lucidum belongs to a kind of medicinal fungi plant of Basidiomycetes Polyporaceae Ganoderma, and Reishi sporule is ganoderma lucidum in growth and maturity
The reproduction cell ejected from cap, also referred to as basidiospore have and inhibit tumour, improve immunity, is hypoglycemic and anti-oxidant
Equal multi-efficiencies.Effect of ganoderma lucidum mystery is in addition to containing abundant ganoderma lucidum polysaccharide, terpene, adenosine, amino acid and micro member in it
A variety of pharmacological components such as element, especially organic germanium, it can change acidic constitution of human body, remove phthiremia impurity.
Umbellate pore furgus is the ministerial drug of the present invention, contains ergosterol, α hydroxyls -24 carbonic acid, biotin, water in extract of Zhuling
The cancer preventing and treatings effective ingredients such as dissolubility poly sugar compounds such as grifola polysaccharide and crude protein.Experiment shows that grifola polysaccharide can improve T
Cellular immune function has adjustment effect to humoral immunity, and the weakling of immunologic hypofunction can be made hale and hearty.Study table
Bright, contained grifola polysaccharide in umbellate pore furgus also increases the accumulation of hepatic glycogen, promotes the effect of liver cell regeneration.Umbellate pore furgus can improve pair
The phagocytic activity of cell promotes the immune of cell, and acting with promotion hepatitis surface antibody.
Dandelion, for the adjutant of the present invention, dandelion enters Liver Channel.Liver protection, clear liver poison, and Chinese medicine thinks, dandelion bitter but sweet flavor
Cold in nature, Return liver, stomach have clearing heat and detoxicating, carbuncle that disappears dissipating bind, anti-inflammatory, cool blood, diuresis, cholagogic, hypocatharsis, stomach invigorating, anti-cancer etc. a variety of
Function.Choline in dandelion extract can accelerate phosphatide to synthesize, thus can accelerate cell repair speed, have to liver cell bright
Aobvious protective effect.
Schisandra chinensis makes medicine, schizandrin A, B prime, C prime, alcohol first, alcohol second, ester in Chinese Magnoliavine Fruit alcohol extract for the present invention
First, ester the second grade has obvious protective function to animal liver cell damage caused by chemical toxicant, can inhibit the release of transaminase, makes third
Propylhomoserin transferase (ALT) activity reduces.
Above-mentioned Chinese medicine composition chooses the Chinese medicine of integration of drinking and medicinal herbs, according to the theory of Chinese medicine " monarch ", to above-mentioned five
Kind Pharmaceutical ingredients carry out scientific compatibility, it is proposed that effective pharmaceutical composition can enhance the immunity of hepatopath, promote internal
The discharge of toxin does not have any toxic side effect to promoting hepatopathy rehabilitation significant effect to human body.
In one of the embodiments, the ganoderma spove powder be 18~22 parts, the Ganodenna Lucidum P.E be 18~
22 parts, the extract of Zhuling is 18~22 parts, and the dandelion extract is 18~22 parts, and the Schisandra chinens P.E is 18
~22 parts.
Further, the ganoderma spove powder is 20 parts, and the Ganodenna Lucidum P.E is 20 parts, the extract of Zhuling
It it is 20 parts, the dandelion extract is 20 parts, and the Schisandra chinens P.E is 20 parts.
The sporoderm-broken rate of the ganoderma spove powder is more than 95% in one of the embodiments,.
The ganoderma spove powder is Reishi sporule through the Ultramicro-powder obtained by broken wall, institute in one of the embodiments,
The broken wall step for stating ganoderma spove powder includes:After carrying out Microwave Pretreatment to Reishi sporule under vacuum, liquid is carried out
Nitrogen deep cooling freezing processing freezes to the temperature of the Reishi sporule and is less than or equal to -30 DEG C, then carries out air-flow crushing.
Reishi sporule have double-layer cell wall, be mainly chitin, cause its tough and tensile cell wall, acid and alkali-resistance, it is resistance to enzymolysis,
The properties such as anti-digestion, pressure-resistant heat resistanceheat resistant, hinder human body digesting and assimilating and utilizing to effective component of ganoderma lucidum spore powder.It first passes through micro-
Wave pretreatment makes the chitin fiber of Reishi sporule wall be broken, and improves the brittleness of Reishi sporule wall, and reduce in lucidum spore powder
The content of water, then liquid nitrogen deep freezing processing is carried out, the brittleness of Reishi sporule wall is further increased, is carried out to lucidum spore powder
When air-flow crushing, water content is lower, and the brittle degree of conidial cell wall is higher, easier broken wall, and shell-broken effect is better.
The Ganodenna Lucidum P.E, extract of Zhuling, dandelion extract and Schisandra chinensis extraction in one of the embodiments,
Object be respectively ganoderma lucidum, umbellate pore furgus, dandelion and Schisandra chinensis after crushed, with volumetric concentration be 65%~75% ethanol water soak
40h~50h is carried, is filtered, filtrate is obtained, concentrates the medicinal extract of gained after filtrate, the relative density of the medicinal extract is 1.1~1.15.
Another object of the present invention is to provide a kind of preparation method of the Chinese medicine composition for conditioning and treating hepatopathy, including
Following steps:
Reishi sporule is taken, after carrying out Microwave Pretreatment to Reishi sporule under vacuum, is carried out at liquid nitrogen deep freezing
Reason freezes to the temperature of the Reishi sporule and is less than or equal to -30 DEG C, then carries out air-flow crushing, obtain ganoderma spove powder;
After respectively crushing ganoderma lucidum, umbellate pore furgus, dandelion and Schisandra chinensis, it is 65%~75% ethyl alcohol to use volumetric concentration respectively
Aqueous solution extracts 40h~50h, and filtering obtains filtrate, obtains the medicinal extract that relative density is 1.1~1.15 after concentrating filtrate, that is, distinguishes
Obtain Ganodenna Lucidum P.E, extract of Zhuling, dandelion extract and Schisandra chinens P.E;
Take 15~25 parts of ganoderma spove powders, 15~25 parts of Ganodenna Lucidum P.Es, 15~25 parts of umbellate pore furgus
Extract, 15~25 parts of dandelion extracts and 15~25 parts of Schisandra chinens P.Es, each component is mixed, you can.
The temperature of the microwave treatment is 30 DEG C~40 DEG C in one of the embodiments, and the time is 10min~20min.
In this way, to Reishi sporule progress microwave treatment it is possible to prevente effectively from the oxygen of Reishi sporule under vacuum low-temperature environment
Change, reduces influence of the oxygen in air to nutriment in Reishi sporule, and low temperature environment effectively can overcome microwave to spirit
The heat damage that the heat effect of Ganoderma lucidum spore generates can fully maintain the ganoderma lucidum polysaccharide contained in Reishi sporule powder raw material, three
The effect of active ingredients high-content such as terpene, organic germanium, raising product.
In one of the embodiments, the Ganodenna Lucidum P.E be ganoderma lucidum fruitbody after crushed, be with volumetric concentration
65%~75% ethanol water extraction 40h~50h, filtering, filtrate concentration after gained medicinal extract, the medicinal extract it is relatively close
Degree is 1.1~1.15.
Further, the mass volume ratio of the ganoderma lucidum fruitbody and the ethanol water is 1g:(15~20) mL.
The mass volume ratio of the umbellate pore furgus and the ethanol water is 1g in one of the embodiments,:(15~20)
mL。
The mass volume ratio of the dandelion and the ethanol water is 1g in one of the embodiments,:(10~
20)mL。
The mass volume ratio of the Schisandra chinensis and the ethanol water is 1g in one of the embodiments,:(10~
20)mL。
In one of the embodiments, the preparation method further include above-mentioned Chinese medicine composition is dried, powder processed
Step.
Further, the step of the drying is that the Chinese medicine composition is carried out microwave drying under vacuum environment.Such as
This, play the role of uniformly, rapid draing while can also sterilize.Water is the strongly absorbing medium of microwave, and microwave can allow microorganism
In hydrone formed galvanic couple polarity and with electric field change and high speed transport, cause membrane structure to rupture, hydrogen between cellular elements
Key destroys, to have the function that sterilization.
Specifically, vacuum microwave drying case can be used, processing is dried.
Another object of the present invention is to provide a kind of above-mentioned Chinese medicine composition and is preparing for assisting in hepatic drug
Application.
Another object of the present invention is to provide a kind of pharmaceutical preparation, is with the above-mentioned Chinese medicine group for conditioning and treating hepatopathy
Conjunction object is active constituent.
Further, the pharmaceutical preparation can be with the Chinese medicine composition and medically acceptable pharmaceutic adjuvant,
The various dosage forms for being suitable for clinical application, including but not limited to capsule, granule, piece are made by the conventional method of pharmaceutical preparation
The dosage forms such as agent, oral solution.
The invention has the advantages that:
1), the present invention chooses the Chinese medicine of five tastes integration of drinking and medicinal herbs, it then follows the principles of formulating prescriptions of Chinese medicine " monarch ", with ganoderma lucidum
With ganoderma spove powder be monarch drug in a prescription, umbellate pore furgus is ministerial drug, dandelion is adjutant, Schisandra chinensis is to make medicine, reasonable formula, all medicine phases
The effect of closing, playing tonifying liver tonifying speen and tonifying kidney, promoting blood circulation toxin expelling, can enhance the immunity of hepatopath, aobvious to hepatopathy rehabilitation effect
It writes, has the characteristics that have no toxic and side effect to human body, is stable and controllable for quality, having a good application prospect in hepatopathy rehabilitation field.
2), Chinese medicine composition of the present invention selects ganoderma spove powder, Ganodenna Lucidum P.E, extract of Zhuling, dandelion to carry
It is that raw material carries out prescription to take object and Schisandra chinens P.E, more convenient to use to which taking dose is small.
Specific implementation mode
To facilitate the understanding of the present invention, below will to invention is more fully described, and give the present invention compared with
Good embodiment.But the present invention can realize in many different forms, however it is not limited to embodiment described herein.Phase
Instead, purpose of providing these embodiments is makes the disclosure of the present invention more thorough and comprehensive.
Unless otherwise defined, all of technologies and scientific terms used here by the article and belong to the technical field of the present invention
The normally understood meaning of technical staff is identical.Used term is intended merely to description tool in the description of the invention herein
The purpose of the embodiment of body, it is not intended that in the limitation present invention.Term as used herein "and/or" includes one or more phases
Any and all combinations of the Listed Items of pass.
A kind of Chinese medicine composition for conditioning and treating hepatopathy of embodiment 1
1, the formula of Chinese medicine composition:20 parts of ganoderma spove powder, 20 parts of Ganodenna Lucidum P.E, 20 parts of extract of Zhuling,
20 parts of dandelion extract, 20 parts of Schisandra chinens P.E.
2, each component raw material
1), ganoderma spove powder
Ganoderma spove powder is the drying spore of On Polyporaceae red sesame or purple sesame through the Ultramicro-powder obtained by broken wall, is pressed
NY/T1677-2008《The measurement of ganoderma spove powder sporoderm-broken rate》, it is desirable that broken rate must not be less than 95%, can also pass through
Commercially available purchase can also be prepared by the following method and obtain:
Reishi sporule is taken, pretreatment 15min is carried out to Reishi sporule using microwave under 30 DEG C~40 DEG C of cryogenic conditions,
Liquid nitrogen deep freezing processing is carried out to Reishi sporule using liquid nitrogen deep instant freezer, is frozen to donor center temperature to -35 DEG C, then
Supersonic airstream broken wall is carried out at -10 DEG C using supersonic jet mill, crushing mesh number is 800 mesh, obtains wall-broken ganoderma spore
Powder, sporoderm-broken rate reach 99.5%.
2), Ganodenna Lucidum P.E
Ganodenna Lucidum P.E is extract made of ganoderma lucidum fruitbody warp adds, can be by commercially available purchase, also can be by following
Method is prepared:
Ganoderma lucidum fruitbody is taken, coarse powder (30 mesh) is ground into, is 1g by the mass volume ratio of ganoderma lucidum coarse powder and ethyl alcohol:18mL,
With the alcohol solvent of 70vol%, after impregnating ganoderma lucidum coarse powder 48h, filtrate is collected in filtering, and ethyl alcohol is recovered under reduced pressure and is concentrated into opposite
Density is the medicinal extract of 1.1~1.15 (65 DEG C), obtains Ganodenna Lucidum P.E, extract yield 8.6%.
3), extract of Zhuling
Extract of Zhuling be On Polyporaceae umbellate pore furgus sclerotium through plus made of extract, can by commercially available purchase,
Also it can be prepared by the following method and obtain:
Dry sclerotia is taken, coarse powder (30 mesh) is ground into, is 1g by the mass volume ratio of umbellate pore furgus coarse powder and ethyl alcohol:
15mL, with the alcohol solvent of 70vol%, after impregnating umbellate pore furgus coarse powder 48h, filtering collects filtrate, ethyl alcohol is recovered under reduced pressure and is concentrated into
Relative density is the medicinal extract of 1.1~1.15 (65 DEG C), obtains extract of Zhuling, extract yield 9.1%.
4), dandelion extract
Dandelion extract be dandelion herb through plus made of extract, can by commercially available purchase, also can by with
Lower section method is prepared:
Dandelion herb is ground into coarse powder (30 mesh), is 1g by the mass volume ratio of dandelion coarse powder and ethyl alcohol:15mL,
After the alcohol dipping dandelion coarse powder 48h of 70vol%, filtrate is collected in filtering, and ethyl alcohol is recovered under reduced pressure and is concentrated into relative density
For the medicinal extract of 1.1~1.15 (65 DEG C), dandelion extract, extract yield 7.5% are obtained.
5), Schisandra chinens P.E
Schisandra chinens P.E is the dry mature fruit warp of magnoliaceae schisandra plus manufactured extract, can be passed through
Commercially available purchase can also be prepared by the following method and obtain:
The dry mature fruit of Schisandra chinensis is ground into coarse powder (30 mesh), by the mass volume ratio of Schisandra chinensis coarse powder and ethyl alcohol
For 1g:10mL, after the alcohol dipping Schisandra chinensis coarse powder 48h of 70vol%, filtering collects filtrate, ethyl alcohol is recovered under reduced pressure and concentrates
To the medicinal extract that relative density is 1.1~1.15 (65 DEG C), Schisandra chinens P.E, extract yield 8.8% are obtained.
Embodiment 2 is used for the granule of auxiliary treatment hepatopathy
2000 grams of ganoderma spove powder in above-described embodiment 1,2000 grams of Ganodenna Lucidum P.E, umbellate pore furgus extraction are weighed respectively
2000 grams of object, 2000 grams of dandelion extract, 2000 grams of Schisandra chinens P.E.
The mixture of above-mentioned four kinds of extracts and ganoderma spove powder is placed in vacuum microwave drying case, it is dry in 40 DEG C
Dry 30min, then powder processed, is processed into particle electuary, per 3 grams of parcel.
Embodiment 3
Embodiment 3 is substantially the same manner as Example 2, the difference is that:Ganoderma spove powder is 250 grams, ganoderma lucidum is extracted
Object is 150 grams, extract of Zhuling is 150 grams, and dandelion extract is 230 grams, and Schisandra chinens P.E is 220 grams.
Embodiment 4
Embodiment 4 is substantially the same manner as Example 2, the difference is that:Ganoderma spove powder is 200 grams, ganoderma lucidum is extracted
Object is 250 grams, extract of Zhuling is 250 grams, and dandelion extract is 150 grams, and Schisandra chinens P.E is 150 grams.
Embodiment 5
Embodiment 5 is substantially the same manner as Example 2, the difference is that:Ganoderma spove powder is 180 grams, ganoderma lucidum is extracted
Object is 220 grams, extract of Zhuling is 220 grams, and dandelion extract is 180 grams, and Schisandra chinens P.E is 200 grams.
Comparative example 1
Comparative example 1 is substantially the same manner as Example 2, the difference is that:Ganoderma spove powder is 100 grams, ganoderma lucidum is extracted
Object is 200 grams, extract of Zhuling is 200 grams, and dandelion extract is 200 grams, and Schisandra chinens P.E is 200 grams.
Comparative example 2
Comparative example 2 is substantially the same manner as Example 2, the difference is that:Ganoderma spove powder is 200 grams, ganoderma lucidum is extracted
Object is 200 grams, extract of Zhuling is 100 grams, and dandelion extract is 200 grams, and Schisandra chinens P.E is 200 grams.
Comparative example 3
Comparative example 3 is substantially the same manner as Example 2, the difference is that:Ganoderma spove powder is 200 grams, ganoderma lucidum is extracted
Object is 200 grams, extract of Zhuling is 200 grams, and dandelion extract is 100 grams, and Schisandra chinens P.E is 200 grams.
Comparative example 4
Comparative example 4 is substantially the same manner as Example 2, the difference is that:Ganoderma spove powder is 200 grams, ganoderma lucidum is extracted
Object is 200 grams, extract of Zhuling is 200 grams, and dandelion extract is 200 grams, and Schisandra chinens P.E is 100 grams.
The Chinese medicine composition of 6 Application Example 2~5 of embodiment and comparative example 1~4 causes D-Gal (D-Gla)
The Protection of acute liver
Experiment material:80 Kunming mouses, male, weight 20g ± 2g are randomly divided into 8 groups, every group 10:Model group,
The granule group of Normal group, bifendate positive controls (25mg), embodiment 2~5 and comparative example 1~4
(100mg).Ad lib, drinking-water, natural light irradiation before experiment.
Experimental method:Each medication group mouse distinguishes gastric infusion 1 time daily, and normal group and model group are with isometric physiology salt
Water gavage 20mL/ (kgd), continuous 10 days.After last medication about 6h, in addition to Normal group, remaining equal abdomen of each group mouse
Chamber injects 1%D- amine-galactoses normal saline solution (200mg/kg).It is deprived of food but not water, takes a blood sample and take afterwards for 24 hours hepatic tissue, examine
It surveys serum transaminase ALT (alanine aminotransferase), AST (glutamic-oxalacetic transaminease) level and liver MDA (malonaldehyde) is horizontal, as a result see
The following table 1.
Table 1
Group | ALT(U/L) | AST(U/L) | MDA(nmol/mgprot) |
Normal group | 28.25±5.52 | 113.16±9.24 | 10.52±1.948 |
Model group | 163.45±11.87 | 275.61±18.5 | 34.36±6.45 |
Bifendate control group | 81.25±8.97 | 201.35±10.28 | 19.49±4.36 |
2 granule group of embodiment | 106.75±9.65 | 213.19±11.64 | 21.57±2.80 |
3 granule group of embodiment | 138.94±9.87 | 234.28±12.13 | 27.07±3.58 |
4 granule group of embodiment | 136.75±9.65 | 237.19±11.64 | 27.50±2.81 |
5 granule group of embodiment | 123.75±9.65 | 209.15±10.73 | 24.57±2.55 |
1 granule group of comparative example | 155.02±10.73 | 265.43±12.4 | 30.89±3.52 |
2 granule group of comparative example | 154.37±9.52 | 263.36±11.72 | 31.97±3.24 |
3 granule group of comparative example | 155.94±9.87 | 266.28±12.32 | 32.07±3.58 |
4 granule group of comparative example | 157.64±9.54 | 268.46±10.25 | 31.79±3.65 |
As a result:
Serum transaminase is the sensitive indicator of hepatocellular damage, and the most commonly used is ALT and AST.MDA is that free radical is attacked
The peroxidatic reaction of lipid product of biomembrane initiation is hit, the content in tissue can reflect level of lipid peroxidation, reflect indirectly
Go out the degree that cell is attacked and damaged by free radical.
Compared with Normal group, ALT, AST are horizontal in model group mice serum and liver MDA level significantly increases,
Show that D-Gal destroys the antioxidant system of liver, damage is caused to liver cell.And bifendate group, embodiment 2~5 with
And 1~4 granule group of comparative example is compared with model group, can reduce to varying degrees ALT and AST enzymes activity and
The level of MDA illustrates to have certain protective action to acute liver damage caused by D-Gal.
But 1~4 above-mentioned five kind of raw material of embodiment 2~5 and comparative example combines the Chinese medicine composition of formation in varing proportions
Granule in, it is optimal with the effect of embodiment 2.Model group is compared, although 1~4 granule group of comparative example can be to a certain degree
The upper MDA for reducing ALT, AST is horizontal, but effect unobvious;The effect that embodiment 2~5 reduces the MDA levels of ALT, AST is bright
It is aobvious, and 2 granule group of embodiment and the significant difference of model control group, D-Gal acute hepatic injury mice blood can be significantly inhibited
ALT and AST activity levels in clear, and the reduction of MDA contents is acted on obviously, the denaturation and necrosis of hepatic tissue can be mitigated, it is right
Hepatic injury has good protective action.
Embodiment 7 imitates the granule clinical trial with the Chinese medicine composition for promoting hepatopathy rehabilitation effect of embodiment 2
Fruit is verified
Instructions of taking:Sooner or later each daily edible primary, 3 grams every time.
Present inventor began one's study from 2010, and formula has constantly been improved since 8 years, 313 formulas was done and changes
Into experiment, there are several hepatopaths to eat the product of the present invention, wherein hepatopath on the books 19, wherein man 11,
Female 8,40 years old 3 below, 5 of 40 or more years old, 6 of 50 years old or more, 5 of 60 or more years old, total effective rate reaches
95.3%, obvious effective rate reaches 81.7%, restores normal person after 12 months edible and leads up to 81.6%, now takes passages three patient's cases for example
Under:
Huang, man, 43 years old 2010, hepatitis B is diagnosed as through People's Hospital, Hunan Prov., and patient's gastric disorder causing nausea is indigestion and loss of appetite, detests oil, burnout
It is weak, eyes are yellow, therapeutic effect is bad for many years, and paddy transaminase continued jitters are checked in 310~385 units per liters to hospital, we
It is recommended that Huang on the basis of drug therapy, eats the product of conditioning the embodiment of the present invention 2, adjustment has apparent effect in 6 months
Fruit, in being off drug, symptom completely disappears at 1 year, and paddy transaminase still controls very well, present Huang 51 years old, feels
Very healthy, now substantially free from taking medicine, check also remains always normal, obtains significant rehabilitation conditioning effect.
46 years old 2012, hepatitis B is diagnosed as through Xiang Ya hospitals of Hunan Province by poplar, man, patient's self-induction malaise, it is indigestion and loss of appetite not
It is intended to eat, detests that oil, urine color be yellow, pore membrane xanthochromia, and right flank distending pain occur, paddy transaminase is checked in 310 units per liters to hospital, it is more
Year therapeutic effect is bad, it is proposed that Huang on the basis of drug therapy, eats the product of the conditioning present invention, adjusts 8 months
It has obvious effects on, in being off drug, symptom completely disappears when 1 year edible, and paddy transaminase still controls very well, present poplar
Certain 53 years old, feel very healthy, now substantially free from taking medicine, check also remains always normal, obtains significant rehabilitation
Conditioning effect.
41 years old 2012, hepatic sclerosis is diagnosed as through Xiang Ya hospitals of Hunan Province by Liu, female, patient's self-induction general malaise is weak,
Indigestion and loss of appetite loss of appetite, urine color Huang, pore membrane xanthochromia, and detest oil, paddy transaminase is checked in 400 units per liters to hospital, and treatment for many years is imitated
Fruit is bad, it is proposed that Liu on the basis of drug therapy, improves the product for eating the present invention, conditioning has apparent for 6 months
Effect, in being off drug, symptom completely disappears when 1 year edible, and paddy transaminase is down to 50 units per liters, and present Liu 48
In year, feel very healthy, index full recovery always is normal, obtains significant rehabilitation conditioning effect.
Each technical characteristic of embodiment described above can be combined arbitrarily, to keep description succinct, not to above-mentioned reality
It applies all possible combination of each technical characteristic in example to be all described, as long as however, the combination of these technical characteristics is not deposited
In contradiction, it is all considered to be the range of this specification record.
Several embodiments of the invention above described embodiment only expresses, the description thereof is more specific and detailed, but simultaneously
It cannot therefore be construed as limiting the scope of the patent.It should be pointed out that coming for those of ordinary skill in the art
It says, without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to the protection of the present invention
Range.Therefore, the protection domain of patent of the present invention should be determined by the appended claims.
Claims (10)
1. a kind of Chinese medicine composition for conditioning and treating hepatopathy, which is characterized in that the Chinese medicine composition is by following parts by weight
The raw material of proportioning forms:
2. Chinese medicine composition according to claim 1, which is characterized in that the ganoderma spove powder is 18~22 parts,
The Ganodenna Lucidum P.E is 18~22 parts, and the extract of Zhuling is 18~22 parts, and the dandelion extract is 18~22 parts,
The Schisandra chinens P.E is 18~22 parts.
3. Chinese medicine composition according to claim 1, which is characterized in that the ganoderma spove powder is 20 parts, described
Ganodenna Lucidum P.E is 20 parts, and the extract of Zhuling is 20 parts, and the dandelion extract is 20 parts, the Schisandra chinens P.E
It is 20 parts.
4. Chinese medicine composition according to claim 1, which is characterized in that the ganoderma spove powder passes through for Reishi sporule
The step of Ultramicro-powder obtained by broken wall, the broken wall includes:Microwave Pretreatment is carried out to the Reishi sporule under vacuum
Afterwards, liquid nitrogen deep freezing processing is carried out, freezes to the temperature of the Reishi sporule and is less than or equal to -30 DEG C, then carry out air-flow powder
It is broken.
5. Chinese medicine composition according to claim 1, which is characterized in that the Ganodenna Lucidum P.E, extract of Zhuling, Pu Gong
English extract and Schisandra chinens P.E be respectively ganoderma lucidum, umbellate pore furgus, dandelion and Schisandra chinensis after crushed, with volumetric concentration be 65%
~75% ethanol water extracts 40h~50h, and filtering obtains filtrate, concentrates the medicinal extract of gained after filtrate, the phase of the medicinal extract
It is 1.1~1.15 to density.
6. a kind of preparation method of Chinese medicine composition for conditioning and treating hepatopathy, which is characterized in that include the following steps:
Reishi sporule is taken, after carrying out Microwave Pretreatment to Reishi sporule under vacuum, liquid nitrogen deep freezing processing is carried out, freezes
Temperature to the Reishi sporule is less than or equal to -30 DEG C, then carries out air-flow crushing, obtains ganoderma spove powder;
After respectively crushing ganoderma lucidum, umbellate pore furgus, dandelion and Schisandra chinensis, the ethyl alcohol for using volumetric concentration to be 65%~75% respectively is water-soluble
Liquid extracts 40h~50h, and filtering obtains filtrate, obtains the medicinal extract that relative density is 1.1~1.15 after concentrating filtrate, that is, respectively obtains
Ganodenna Lucidum P.E, extract of Zhuling, dandelion extract and Schisandra chinens P.E;
Take 15~25 parts of ganoderma spove powders, 15~25 parts of Ganodenna Lucidum P.Es, 15~25 parts of umbellate pore furgus extractions
Object, 15~25 parts of dandelion extracts and 15~25 parts of Schisandra chinens P.Es, each component is mixed, you can.
7. preparation method according to claim 6, which is characterized in that the temperature of the microwave treatment is 30 DEG C~40 DEG C,
Time is 10min~20min.
8. preparation method according to claim 6, which is characterized in that the volumetric concentration of the ethanol water is 70%.
9. application of any Chinese medicine composition of Claims 1 to 5 in preparing the drug for auxiliary treatment hepatopathy.
10. using any Chinese medicine composition of Claims 1 to 5 as the pharmaceutical preparation of active constituent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810993245.7A CN108704032A (en) | 2018-08-29 | 2018-08-29 | Chinese medicine composition and its preparation method and application for conditioning and treating hepatopathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810993245.7A CN108704032A (en) | 2018-08-29 | 2018-08-29 | Chinese medicine composition and its preparation method and application for conditioning and treating hepatopathy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108704032A true CN108704032A (en) | 2018-10-26 |
Family
ID=63873456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810993245.7A Withdrawn CN108704032A (en) | 2018-08-29 | 2018-08-29 | Chinese medicine composition and its preparation method and application for conditioning and treating hepatopathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108704032A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111643617A (en) * | 2020-07-07 | 2020-09-11 | 常德市永春堂生物科技有限公司 | Traditional Chinese medicine composition for conditioning and treating liver diseases and preparation method thereof |
-
2018
- 2018-08-29 CN CN201810993245.7A patent/CN108704032A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111643617A (en) * | 2020-07-07 | 2020-09-11 | 常德市永春堂生物科技有限公司 | Traditional Chinese medicine composition for conditioning and treating liver diseases and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719498B (en) | A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof | |
CN102784363B (en) | Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof | |
CN111035649B (en) | NMN + GLP compound nutritional supplement and preparation method and application thereof | |
WO2014131344A1 (en) | Beverage | |
CN102697035A (en) | Cordyceps anti-aging pellet | |
CN103053733A (en) | Oriental beauty tea with the functions of adjusting the vitality and nourishing the blood, improving microcirculation and tendering skin and beauty and preparation method thereof | |
CN105194083A (en) | Medicine composition for enhancing immunity and resisting radiation and preparation method thereof | |
CN107904103A (en) | A kind of dendrobium candidum health liquor and its preparation method and application | |
CN106214847A (en) | A kind of can the oral liquid and preparation method thereof of enhancing immunity | |
CN108815230A (en) | Chinese medicine composition and its preparation method and application for treating diabetes | |
CN110604800A (en) | Alcohol-dispelling liver-protecting plant beverage for abstinence of alcohol and preparation method thereof | |
CN108743669A (en) | Chinese medicine composition and its preparation method and application for treating goat | |
CN107412665B (en) | It is a kind of that there is Chinese medicine composition for relieving the effect of alcohol, preventing alcoholic liver injury and its preparation method and application | |
CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
CN108704032A (en) | Chinese medicine composition and its preparation method and application for conditioning and treating hepatopathy | |
CN107412713A (en) | Treat Chinese patent drug, dietetic food and the preparation method of autoimmune and immune related diseases | |
CN105617021A (en) | Medicine or health product taking dendrobium officinale and beautiful millettia root as raw materials | |
CN101317900B (en) | Chinese medicinal composition for preventing and controlling alcoholic liver damnification and preparation method thereof | |
CN102078600B (en) | Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same | |
CN107898920A (en) | A kind of mouth containing product and preparation method for diabetes | |
CN104940420A (en) | Traditional Chinese medicine composition with immunity-enhancing function and health food containing traditional Chinese medicine composition and preparation method of health food | |
CN102327304B (en) | Drug for preventing and controlling chronic mountain sickness and preparation method thereof | |
CN105125738A (en) | Traditional Chinese medicinal composition as well as preparation method and application thereof | |
CN101185668A (en) | Novel preparation for preventing and controlling acquired immuno-deficiency syndrome and protecting liver and detoxication | |
CN108324783A (en) | It is white to return ginseng Ling Donggan medicines for cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181026 |
|
WW01 | Invention patent application withdrawn after publication |